New US inversion rules threatens $160b Pfizer-Allergan merger

New US inversion rules threatens $160b Pfizer-Allergan merger

Treasury Secretary Jack Lew | REUTERS/Joshua Roberts

ActavisAllerganBarack ObamaDonald TrumpEvercoreHillary ClintonPfizerUS treasury dept

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from World

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.